Analyst Reco. Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2025-12-05 am EST			5-day change	1st Jan Change
85.00 ^EUR	+0.51%		-0.89%	-9.32%

Dec. 05	SANOFI : Buy rating from Bernstein	ZD
Dec. 05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE

Analyst Reco.

SANOFI : Buy rating from Bernstein	Dec. 05	ZD
SANOFI : Deutsche Bank reiterates its Buy rating	Nov. 25	ZD
SANOFI : Buy rating from Jefferies	Nov. 19	ZD
Sanofi Announces Positive Results from the pivotal LIBERTY- AFRS-AIMS Phase 3 Study	Nov. 07	CI
Regeneron, Sanofi Say Dupixent for Allergic Fungal Rhinosinusitis Met Primary Endpoint in Phase 3 Study	Nov. 07	MT
Sanofi, Regeneron's Dupixent Hits Key Goals in Late-Stage Fungal Allergy Trial	Nov. 07	DJ
Sanofi's Dupixent Achieves Phase 3 Success in Allergic Fungal Rhinosinusitis	Nov. 07
Sanofi and Regeneron's Dupixent meets endpoints, accepted for priority review by FDA	Nov. 07	RE
Berenberg Upbeat on Sanofi's Top Line Growth, R&D Turnaround	Nov. 07	MT
SANOFI : Deutsche Bank reaffirms its Buy rating	Oct. 30	ZD
SANOFI : Goldman Sachs gives a Neutral rating	Oct. 28	ZD
SANOFI : Deutsche Bank gives a Buy rating	Oct. 27	ZD
UBS remains bullish on Sanofi after quarterly results.	Oct. 27
SANOFI : Receives a Buy rating from Jefferies	Oct. 27	ZD
SANOFI : UBS reiterates its Buy rating	Oct. 27	ZD
SANOFI : DZ Bank keeps its Buy rating	Oct. 24	ZD
SANOFI : Investors expect a home run now; earnings beat may not suffice	Oct. 24
SANOFI : Receives a Buy rating from UBS	Oct. 24	ZD
SANOFI : JP Morgan remains its Buy rating	Oct. 24	ZD
SANOFI : Bernstein reiterates its Buy rating	Oct. 24	ZD
SANOFI : Jefferies remains its Buy rating	Oct. 24	ZD
SANOFI : JP Morgan reiterates its Buy rating	Oct. 22	ZD
Sanofi's Efdoralprin Alfa met all primary and key secondary endpoints	Oct. 22	RE
Sanofi's Tzield Accepts for Expanded Review in the US for Stage 3 Type 1 Diabetes Through FDA Commission's National Priority Voucher Pilot Program	Oct. 20	CI
Sanofi's Application for Diabetes Drug Tzield Wins US FDA's Expedited Review	Oct. 20	MT